An evaluation of the potential for drug–drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma – topic of research paper in Clinical medicine. Download scholarly article PDF
Teva, one of the biggest generic makers, joins the the brand-name club
Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters
Teva quits brand lobby PhRMA, in line to lead generic lobby AAM - STAT
Teva Pharmaceuticals | LinkedIn
Teva Pharmaceuticals - Wikipedia
Teva's Key Drugs in Its Specialty Products Pipeline
Teva USA
Teva looks to amp up research collaborations, CEO says
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma